Neuropharmacology & Neurotherapeutics
Donepezil
Sep. 12, 2021
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
(A) Brain MRI with FLAIR sequences revealing hyperintense lesions in the periventricular white matter of both hemispheres, with postgadolinium radial enhancement in T1 sequences (B). (C) Thoracic spine MRI with sagittal T2 images showing diffuse hyperintensities with patchy enhancement postgadolinium injection (D). (E) Follow-up imaging shows diffuse atrophy of the thoracic spinal cord. (Contributed by Dr. Andrew McKeon.)